Borregaard Asa (BRRDF) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Borregaard Asa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.091 -- 00:00:05.153 Good morning everyone and welcome to Borgard's second quarter 2036 00:00:05.153 -- 00:00:07.033 presentation. 00:00:07.033 -- 00:00:12.015 My name is Tom Erik Foss-Jacobsen, I'm the CEO of Borgard and I'll be joined today by 00:00:12.015 -- 00:00:15.096 our CFO Per Bjarne Lyngstad. 00:00:15.096 -- 00:00:19.697 Together we will take you through this agenda. 00:00:20.478 -- 00:00:25.479 I will start with the key highlights for the quarter and then give an update on the market 00:00:25.479 -- 00:00:29.315 situation across our business segments. 00:00:29.315 -- 00:00:34.298 I will then summarize the outlook before handing over to Per Bjarne. 00:00:34.298 -- 00:00:39.020 He will walk you through the financial performance then in more detail. 00:00:39.021 -- 00:00:44.604 Before we begin, just a quick reminder to those of you watching the webcast 00:00:44.604 -- 00:00:50.108 that you're welcome to submit questions at any time during the presentation 00:00:50.108 -- 00:00:53.629 and we'll address them at the end. 00:00:56.552 -- 00:00:58.913 Let's begin with the highlights 00:00:58.913 -- 00:01:01.394 for the second quarter. 00:01:01.394 -- 00:01:04.595 EBITDA came in at 515 00:01:04.595 -- 00:01:08.457 million Norwegian kroner, compared with 522 00:01:08.457 -- 00:01:11.538 million in the same quarter last year. 00:01:11.538 -- 00:01:16.640 This is a solid result, broadly in line with a strong second quarter last 00:01:16.640 -- 00:01:18.200 year, 00:01:18.200 -- 00:01:23.693 and also supported by good operational performance in the quarter. 00:01:23.693 -- 00:01:28.736 Looking at the business areas, biosolutions delivered higher sales volume, but 00:01:28.736 -- 00:01:32.477 with a less favorable product mix. 00:01:32.519 -- 00:01:36.061...